# COQ8A

## Overview
The COQ8A gene encodes a protein known as ADCK3, which is a member of the UbiB family and plays a pivotal role in the biosynthesis of coenzyme Q10 (CoQ10), a crucial component of the mitochondrial electron transport chain. The COQ8A protein is characterized by a protein kinase-like domain, although it functions primarily as an ATPase rather than a kinase, facilitating the assembly and stabilization of the CoQ biosynthetic complex within the inner mitochondrial membrane (Reidenbach2017Conserved; Manolaras2023Mitochondrial). This protein's activity is modulated by interactions with cardiolipin and small molecules, which enhance its ATPase function, essential for CoQ10 production and, consequently, cellular energy metabolism (Awad2018Coenzyme). Mutations in the COQ8A gene can lead to primary CoQ10 deficiencies, resulting in mitochondrial dysfunction and clinical manifestations such as cerebellar ataxia, highlighting its significance in maintaining mitochondrial health (Zhang2020Primary).

## Structure
The COQ8A protein, also known as ADCK3, is part of the UbiB family and plays a crucial role in coenzyme Q (CoQ) biosynthesis. It is characterized by a protein kinase-like (PKL) domain, which adopts a common protein kinase fold consisting of an N-lobe and C-lobe (AbuMaziad2020The). The COQ8A protein interacts with membranes through electrostatic interactions, particularly with negatively charged phospholipids like cardiolipin in the inner mitochondrial membrane. This interaction is facilitated by a positive electrostatic patch formed by the GQaα1 and GQaα4 helices, with key residues R262, R265, and K269 being crucial for membrane binding (Reidenbach2017Conserved).

The COQ8A protein does not undergo autophosphorylation or phosphorylate lipid substrates, supporting its role as an ATPase rather than a kinase (Reidenbach2017Conserved). The protein's ATPase activity is enhanced by cardiolipin-containing membranes and phenolic compounds resembling CoQ intermediates, suggesting a regulatory mechanism linked to its membrane environment (Reidenbach2017Conserved). While specific details on the primary, secondary, tertiary, or quaternary structure of COQ8A are not provided, its interaction with lipids and small molecules is a key aspect of its function (Reidenbach2017Conserved).

## Function
The COQ8A gene encodes a protein that plays a crucial role in the biosynthesis of coenzyme Q10 (CoQ10), a vital component of the mitochondrial electron transport chain. This protein is involved in maintaining the integrity of the CoQ10 biosynthetic complex, also known as Complex Q, and is essential for proper mitochondrial function (Manolaras2023Mitochondrial). COQ8A is located on the matrix face of the inner mitochondrial membrane, where it interacts with CoQ biosynthesis enzymes, acting as a stabilizer of the CoQ biosynthesis complex (Paprocka2022COQ8AAtaxia).

Although COQ8A lacks in vitro protein kinase activity, it exhibits ATPase activity, which is essential for CoQ biosynthesis. This ATPase activity is activated by cardiolipin and small molecule mimics of CoQ intermediates, suggesting a chaperone-like role in facilitating the assembly of the CoQ synthome and the de novo biosynthesis of CoQ (Awad2018Coenzyme). The protein's function is crucial for ATP production, as CoQ10 shuttles electrons between respiratory chain complexes during oxidative phosphorylation, a process vital for cellular energy production (Cotta2020Early‐onset).

Mutations in COQ8A can lead to primary CoQ10 deficiencies, which are associated with mitochondrial dysfunction and various clinical manifestations, including cerebellar ataxia (Zhang2020Primary).

## Clinical Significance
Mutations in the COQ8A gene are associated with a range of mitochondrial disorders, primarily characterized by coenzyme Q10 (CoQ10) deficiency. This deficiency leads to conditions such as autosomal recessive cerebellar ataxia 2 (ARCA2) and spinocerebellar ataxia-9 (SCAR9), collectively known as COQ8A-ataxia (Paprocka2022COQ8AAtaxia; Jacobsen2017Compound). These disorders typically manifest as childhood-onset progressive cerebellar ataxia, developmental regression, and cerebellar atrophy (Paprocka2022COQ8AAtaxia). 

Patients with COQ8A mutations may experience a variety of symptoms, including gait ataxia, exercise intolerance, seizures, and cognitive impairment (Cotta2020Early‐onset; Zhang2020Primary). The clinical presentation can be highly heterogeneous, with some individuals also exhibiting symptoms like dystonia, tremor, and myoclonus (Zhang2020Primary). MRI findings often reveal cerebellar atrophy, a common radiological sign in affected individuals (Traschütz2020Clinico‐Genetic).

Treatment with CoQ10 supplementation has shown variable efficacy, with some patients experiencing improvements in ataxia and daily functioning, while others show limited response (Paprocka2022COQ8AAtaxia; Jacobsen2017Compound). Early diagnosis and treatment are crucial to potentially mitigate severe neurological damage (Jacobsen2017Compound).

## Interactions
COQ8A, also known as ADCK3, is involved in the biosynthesis of coenzyme Q10 and is part of the UbiB protein family. While specific physical interactions of COQ8A with other proteins or nucleic acids are not extensively detailed, it is known to be part of a multiprotein complex involved in coenzyme Q biosynthesis. This complex includes other COQ proteins such as COQ3, COQ4, COQ5, COQ6, COQ7, and COQ9, which are crucial for maintaining coenzyme Q10 levels and mitochondrial function (Reidenbach2017Conserved; Yen2020Characterization).

COQ8A's ATPase activity is modulated by interactions with lipids, particularly cardiolipin, which enhances its membrane binding and activity. This interaction is essential for its function in coenzyme Q biosynthesis, as it helps position COQ8A correctly on the inner mitochondrial membrane (Reidenbach2017Conserved). Additionally, COQ8A's activity can be influenced by small molecules such as 2-propylphenol, which modulates its ATPase activity through allosteric effects, although this does not involve direct binding to the nucleotide site (Murray20222Propylphenol). Despite these insights, specific direct interactions with other proteins or nucleic acids remain to be fully elucidated.


## References


[1. (Manolaras2023Mitochondrial) Ioannis Manolaras, Andrea Del Bondio, Olivier Griso, Laurence Reutenauer, Aurélie Eisenmann, Bianca H Habermann, and Hélène Puccio. Mitochondrial dysfunction and calcium dysregulation in coq8a-ataxia purkinje neurons are rescued by coq10 treatment. Brain, 146(9):3836–3850, March 2023. URL: http://dx.doi.org/10.1093/brain/awad099, doi:10.1093/brain/awad099. This article has 10 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awad099)

[2. (Yen2020Characterization) Hsiu-Chuan Yen, Wen-Yu Yeh, Szu-Hsien Lee, Yu-Hsiu Feng, and Si-Ling Yang. Characterization of human mitochondrial pdss and coq proteins and their roles in maintaining coenzyme q10 levels and each other’s stability. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1861(7):148192, July 2020. URL: http://dx.doi.org/10.1016/j.bbabio.2020.148192, doi:10.1016/j.bbabio.2020.148192. This article has 17 citations.](https://doi.org/10.1016/j.bbabio.2020.148192)

[3. (Murray20222Propylphenol) Nathan H. Murray, Adam Lewis, Juan P. Rincon Pabon, Michael L. Gross, Katherine Henzler-Wildman, and David J. Pagliarini. 2-propylphenol allosterically modulates coq8a to enhance atpase activity. ACS Chemical Biology, 17(8):2031–2038, July 2022. URL: http://dx.doi.org/10.1021/acschembio.2c00434, doi:10.1021/acschembio.2c00434. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1021/acschembio.2c00434)

[4. (Traschütz2020Clinico‐Genetic) Andreas Traschütz, Tommaso Schirinzi, Lucia Laugwitz, Nathan H. Murray, Craig A. Bingman, Selina Reich, Jan Kern, Anna Heinzmann, Gessica Vasco, Enrico Bertini, Ginevra Zanni, Alexandra Durr, Stefania Magri, Franco Taroni, Alessandro Malandrini, Jonathan Baets, Peter de Jonghe, Willem de Ridder, Matthieu Bereau, Stephanie Demuth, Christos Ganos, A. Nazli Basak, Hasmet Hanagasi, Semra Hiz Kurul, Benjamin Bender, Ludger Schöls, Ute Grasshoff, Thomas Klopstock, Rita Horvath, Bart van de Warrenburg, Lydie Burglen, Christelle Rougeot, Claire Ewenczyk, Michel Koenig, Filippo M. Santorelli, Mathieu Anheim, Renato P. Munhoz, Tobias Haack, Felix Distelmaier, David J. Pagliarini, Hélène Puccio, and Matthis Synofzik. Clinico‐genetic, imaging and molecular delineation of <scp>coq8a</scp>‐ataxia: a multicenter study of 59 patients. Annals of Neurology, 88(2):251–263, June 2020. URL: http://dx.doi.org/10.1002/ana.25751, doi:10.1002/ana.25751. This article has 55 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.25751)

5. (Reidenbach2017Conserved) Conserved lipid and small molecule modulation of COQ8 reveals regulation of the ancient UbiB family. This article has 1 citations.

[6. (Jacobsen2017Compound) Jessie C. Jacobsen, Whitney Whitford, Brendan Swan, Juliet Taylor, Donald R. Love, Rosamund Hill, Sarah Molyneux, Peter M. George, Richard Mackay, Stephen P. Robertson, Russell G. Snell, and Klaus Lehnert. Compound Heterozygous Inheritance of Mutations in Coenzyme Q8A Results in Autosomal Recessive Cerebellar Ataxia and Coenzyme Q10 Deficiency in a Female Sib-Pair, pages 31–36. Springer Berlin Heidelberg, 2017. URL: http://dx.doi.org/10.1007/8904_2017_73, doi:10.1007/8904_2017_73. This article has 17 citations.](https://doi.org/10.1007/8904_2017_73)

[7. (Cotta2020Early‐onset) Ana Cotta, Charlotte L. Alston, Sidney Baptista‐Junior, Julia F. Paim, Elmano Carvalho, Monica M. Navarro, Marie Appleton, Yi Shiau Ng, Jaquelin Valicek, Antonio L. da‐Cunha‐Junior, Maria I. Lima, Alessandra de la Rocque Ferreira, Reinaldo I. Takata, Iain P. Hargreaves, Gráinne S. Gorman, Robert McFarland, Germaine Pierre, and Robert W. Taylor. Early‐onset coenzyme q10 deficiency associated with ataxia and respiratory chain dysfunction due to novel pathogenic coq8a variants, including a large intragenic deletion. JIMD Reports, 54(1):45–53, June 2020. URL: http://dx.doi.org/10.1002/jmd2.12107, doi:10.1002/jmd2.12107. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jmd2.12107)

[8. (Awad2018Coenzyme) Agape M. Awad, Michelle C. Bradley, Lucía Fernández-del-Río, Anish Nag, Hui S. Tsui, and Catherine F. Clarke. Coenzyme q10 deficiencies: pathways in yeast and humans. Essays in Biochemistry, 62(3):361–376, July 2018. URL: http://dx.doi.org/10.1042/ebc20170106, doi:10.1042/ebc20170106. This article has 106 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/ebc20170106)

[9. (Paprocka2022COQ8AAtaxia) Justyna Paprocka, Magdalena Nowak, Piotr Chuchra, and Robert Śmigiel. Coq8a-ataxia as a manifestation of primary coenzyme q deficiency. Metabolites, 12(10):955, October 2022. URL: http://dx.doi.org/10.3390/metabo12100955, doi:10.3390/metabo12100955. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/metabo12100955)

[10. (AbuMaziad2020The) Asmaa S. AbuMaziad, Tarjani M. Thaker, Thomas M. Tomasiak, Chyi Chyi Chong, Maureen K. Galindo, and H. Eugene Hoyme. The role of novel <scp>coq8b</scp> mutations in glomerulopathy and related kidney defects. American Journal of Medical Genetics Part A, 185(1):60–67, October 2020. URL: http://dx.doi.org/10.1002/ajmg.a.61909, doi:10.1002/ajmg.a.61909. This article has 5 citations.](https://doi.org/10.1002/ajmg.a.61909)

[11. (Zhang2020Primary) Linwei Zhang, Tetsuo Ashizawa, and Dantao Peng. Primary coenzyme q10 deficiency due to coq8a gene mutations. Molecular Genetics &amp; Genomic Medicine, August 2020. URL: http://dx.doi.org/10.1002/mgg3.1420, doi:10.1002/mgg3.1420. This article has 19 citations.](https://doi.org/10.1002/mgg3.1420)